Metoclopramide-induced supersensitivity psychosis

Annals of Pharmacotherapy

Volumn 36, Issue 9, 2002, Pages 1387-1390

  Lu, Mong Liang ^a   Pan, Jan Jhy ^a   Teng, Hui Wen ^a   Su, Kuan Pin ^a   Shen, Winston W ^a   Gonzàlez, Lydia ^a   Demers, Denyse ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Metoclopramide; Supersensitivity psychosis

Indexed keywords

METOCLOPRAMIDE; ANTIEMETIC AGENT; NEUROLEPTIC AGENT; RISPERIDONE;

AGED; ARTICLE; CASE REPORT; DELUSION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG WITHDRAWAL; HALLUCINATION; HUMAN; LIMBIC CORTEX; LONG TERM CARE; MALE; NAUSEA; PRIORITY JOURNAL; PSYCHOSIS; RECEPTOR SENSITIVITY; SUPERSENSITIVITY; TREATMENT PLANNING; TREMOR; VOMITING; CEREBROVASCULAR ACCIDENT; DRUG HYPERSENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOLOGICAL ASPECT; WITHDRAWAL SYNDROME;

AGED; ANTIEMETICS; ANTIPSYCHOTIC AGENTS; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS, TYPE 2; DRUG HYPERSENSITIVITY; HALLUCINATIONS; HUMANS; MALE; METOCLOPRAMIDE; PSYCHOSES, SUBSTANCE-INDUCED; RISPERIDONE; SUBSTANCE WITHDRAWAL SYNDROME; VOMITING;

EID: 0036707917     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A440     Document Type: Article

References (29)

1. Metoclopramide: An updated review of its pharmacological properties and clinical use
2. Metoclopramide: Pharmacology and clinical application
3. Metoclopramide-induced movement disorders
4. Parkinsonism and tardive dyskinesia associated with long-term metoclopramide therapy
5. Tardive dyskinesia associated with metoclopramide
6. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders
7. Tardive dyskinesia: Summary of a task force. Report of the American Psychiatric Association
8. Labile hypertension after abrupt neuroleptic withdrawal: A case report
9. Dopamine receptor supersensitivity and chemoreceptor trigger zone
10. Hypothalamic dopamine receptor supersensitivity? A pilot study of self-induced water intoxication
11. Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors
12. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine
13. The concept of supersensitivity psychosis
14. Neuroleptic-induced supersensitivity psychosis
15. Tardive psychosis
16. Severe cases of neuroleptic-induced supersensitivity psychosis: Diagnostic criteria for the disorder and its treatment
17. Supersensitivity psychosis and tardive dyskinesia: A survey in schizophrenic outpatients
18. Effects of single and long-term metoclopramide administration on open field and stereotyped behavior of rats
19. Withdrawal effects of metoclopramide
20. Withdrawal syndromes associated with antipsychotic drugs
21. Is there a limbic system equivalent of tardive dyskinesia?
22. Schizophrenia following withdrawal from chronic phenothiazine administration: A case report
23. Psychosis after neuroleptic withdrawal in a manic-depressive patient
24. Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder
25. Neuroleptic-induced supersensitivity psychosis: Clinical and pharmacologic characteristics
26. Neuroleptic withdrawal in schizophrenic patients: A review of literature
27. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment
28. A method for estimating the probability of adverse drug reactions